TRANSTHYRETIN CARDIAC AMYLOIDOSIS
Clinical trials for TRANSTHYRETIN CARDIAC AMYLOIDOSIS explained in plain language.
Never miss a new study
Get alerted when new TRANSTHYRETIN CARDIAC AMYLOIDOSIS trials appear
Sign up with your email to follow new studies for TRANSTHYRETIN CARDIAC AMYLOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
AI-Powered ECG could catch hidden heart disease early
Diagnosis Recruiting nowThis study is testing a cloud-based AI platform called Willem that analyzes electrocardiogram (ECG) data to detect Transthyretin cardiac amyloidosis (ATTR-CA), a rare and serious heart condition. Researchers will compare ECGs from 2000 adults—some with confirmed ATTR-CA and some …
Matched conditions: TRANSTHYRETIN CARDIAC AMYLOIDOSIS
Sponsor: Idoven 1903 S.L. • Aim: Diagnosis
Last updated Jun 27, 2026 14:03 UTC
-
Spine surgery samples could reveal silent heart disease
Diagnosis Recruiting nowThis study looks at tissue removed during back surgery to find early signs of a heart condition called ATTR cardiac amyloidosis. Researchers will test spine samples from 1,663 older adults for abnormal protein deposits. If found, participants will get further heart tests to confi…
Matched conditions: TRANSTHYRETIN CARDIAC AMYLOIDOSIS
Sponsor: Columbia University • Aim: Diagnosis
Last updated Jun 27, 2026 13:02 UTC
-
Sound waves aim to boost heart health in amyloidosis patients
Knowledge-focused Recruiting nowThis study tests whether a special ultrasound treatment, combined with a contrast agent, can improve blood flow and heart function in people with cardiac amyloidosis. Researchers will measure changes using PET scans and echocardiograms. The trial includes 70 participants with and…
Matched conditions: TRANSTHYRETIN CARDIAC AMYLOIDOSIS
Phase: PHASE4 • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC